Article

Case report: A Novel Intergenic KIF5B-MET Fusion Variant in a Patient with Gastric Cancer

2020-09-04

Abstract excerpt

<title>Abstract</title> <p>BackgroundMET fusion is a key driver mutation, but it is rare in gastric cancer (GC). Several MET inhibitors have been approved for the treatment of MET-positive patients, but the tumor response is heterogeneous. With the development of next-generation sequencing (NGS), diverse MET fusion partner genes have been identified. We reported a case of a fusion variant involving KIF5B-MET in G...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 951bc3e8-e46a-5222-86c4-0121a14cc5a3
DOI: 10.21203/rs.3.rs-60984/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case report: A Novel Intergenic KIF5B-MET Fusion Variant in a Patient with Gastric CancerDOI 10.21203/rs.3.rs-60984/v1Read

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.Semantic proximity Read

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.Semantic proximity Read

Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencingSemantic proximity Read

Effective Treatment With Endostar and Crizotinib Sequential Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases Harboring a Novel CLHC1/RNT4 Intergenic Region- ALK FusionSemantic proximity Read

MET fusions are targetable genomic variants in the treatment of advanced malignancies.Semantic proximity Read

Identification of a novel GOPC-RET fusion in a patient with lung adenocarcinoma: A case reportSemantic proximity Read

A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case ReportSemantic proximity Read

Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study.Semantic proximity Read

Molecular and clinicopathological characteristics of EGFR gene fusions in 35,023 Chinese patients with solid tumorsSemantic proximity Read

Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcomeSemantic proximity Read

Unveiling the Uncommon: Targeting Rare MET Fusions in NSCLC: A Comprehensive ReviewSemantic proximity Read

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.Semantic proximity Read